NCT04526262: Assessment of Initial Efficacy and Safety of High Intensity Focused Ultrasound 'ExAblate 4000 Type 2' for Blood Brain Barrier Disruption in Patients With Alzheimer's Disease
- State
- State not given
- Phase
- No phase
- People
- 6 planned
- Started
- 10 Apr 2020
- Primary completion
- Dec 2020
- Arms
- BBB disruption
- Results
- None posted
- 10 Apr 2020: Trial started
- 25 Aug 2020: Trial registered